Bing Xu, GM of Vital River Laboratories, shares the company’s development in the last 20 years; the challenges of advantages of their JV with Charles River Laboratories; the importance of lab animals for the research & development of new drugs and therapies; their core capabilities and competitive advantage as the market leader; and his mission to continue their expansion in China in the coming years.
Even though lab animals make up only a limited portion of the total cost of new drug development, they are very important for every R&D process – without the data from in-vivo research using animals, scientists cannot continue their studies with patients
